A Cost-Effective Alternative for Treating Staphylococcal Bloodstream Infections

Explore a conference talk from ICAAC 2015 that delves into a cost-effective alternative for treating staphylococcal bloodstream infections. Learn about research comparing clinical outcomes between patients receiving nafcillin and cefazolin for treating MSSA bacteremia. Discover how this alternative therapy benefits both patients and hospitals. Gain insights from clinical pharmacy experts as they discuss their study timeline, results, and key takeaways. Engage with audience Q&A sessions covering topics such as betalactamase production and education. Understand the potential impact of this research on standard therapy practices for staphylococcal bloodstream infections.

Introduction
Meet the presenters
Background
Results
Study timeline
Moving to Hartford
Take away message
Audience QA
Betalactamase production
Education
Questions